Paper29344744
Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer.
Gong Z and 8 others. Int J Clin Oncol, 2018. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer. Papers, record 29344744. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29344744
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interleukin 1 Receptor Antagonist Protein | Major topic |
| Neovascularization, Pathologic | Major topic |
| Receptors, Interleukin-1 | Major topic |
| Signal Transduction | Major topic |
| Stomach Neoplasms | Major topic |
| Cell Proliferation | |
| Cells, Cultured | |
| Human Umbilical Vein Endothelial Cells | |
| Humans |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 81260325 | National Natural Science Foundation of China | PubMed |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15504909 | Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. | J Cell Biol | 2004 | https://conductscience.org/library/papers/15504909 | PubMed |
| 2 | 7515134 | Factors influencing the natural history of colorectal liver metastases. | Lancet | 1994 | https://conductscience.org/library/papers/7515134 | PubMed |
| 3 | 12009331 | Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. | Matrix Biol | 2002 | https://conductscience.org/library/papers/12009331 | PubMed |
| 4 | 19437103 | PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells. | Mol Cell Biochem | 2009 | https://conductscience.org/library/papers/19437103 | PubMed |
| 5 | 25147739 | Molecular regulation of bone marrow metastasis in prostate and breast cancer. | Bone Marrow Res | 2014 | https://conductscience.org/library/papers/25147739 | PubMed |
| 6 | 15967832 | VEGF-targeted therapy: therapeutic potential and recent advances. | Oncologist | 2005 | https://conductscience.org/library/papers/15967832 | PubMed |
| 7 | 9679982 | Interleukin-1 regulates interleukin-6 secretion in human oral squamous cell carcinoma in vitro: possible influence of p53 but not human papillomavirus E6/E7. | Cancer Res | 1998 | https://conductscience.org/library/papers/9679982 | PubMed |
| 8 | 15886312 | Angiogenesis and lung cancer: prognostic and therapeutic implications. | J Clin Oncol | 2005 | https://conductscience.org/library/papers/15886312 | PubMed |
| 9 | 10971784 | Infections as a major preventable cause of human cancer. | J Intern Med | 2000 | https://conductscience.org/library/papers/10971784 | PubMed |
| 10 | 12501168 | Enhancement of integrins by interleukin-1alpha, and their relationship with metastatic and invasive behavior of human pancreatic ductal adenocarcinoma cells. | J Surg Oncol | 2003 | https://conductscience.org/library/papers/12501168 | PubMed |
| 11 | 14597552 | A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development. | FASEB J | 2004 | https://conductscience.org/library/papers/14597552 | PubMed |
| 12 | 15084984 | Enhanced angiogenesis due to inflammatory cytokines from pancreatic cancer cell lines and relation to metastatic potential. | Pancreas | 2004 | https://conductscience.org/library/papers/15084984 | PubMed |
| 13 | 26934554 | VEGF promotes gastric cancer development by upregulating CRMP4. | Oncotarget | 2016 | https://conductscience.org/library/papers/26934554 | PubMed |
| 14 | 15944797 | Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up. | Oncol Rep | 2005 | https://conductscience.org/library/papers/15944797 | PubMed |
| 15 | 24790078 | Release of interleukin-1α or interleukin-1β depends on mechanism of cell death. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24790078 | PubMed |
| 16 | 20872950 | Cancer cell-derived IL-1α promotes HGF secretion by stromal cells and enhances metastatic potential in pancreatic cancer cells. | J Surg Oncol | 2010 | https://conductscience.org/library/papers/20872950 | PubMed |
| 17 | 21377040 | Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. | J Allergy Clin Immunol | 2011 | https://conductscience.org/library/papers/21377040 | PubMed |
| 18 | 12147202 | Interleukin-1--a major pleiotropic cytokine in tumor-host interactions. | Semin Cancer Biol | 2002 | https://conductscience.org/library/papers/12147202 | PubMed |
| 19 | 23851506 | Inflammatory chemokines and metastasis--tracing the accessory. | Oncogene | 2014 | https://conductscience.org/library/papers/23851506 | PubMed |
| 20 | 15602010 | Vascular endothelial growth factor and angiogenesis. | Pharmacol Rev | 2004 | https://conductscience.org/library/papers/15602010 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41994022 | Baseline and dynamic cytokines as biomarkers for immune checkpoint and anti-VEGF therapy in advanced hepatocellular carcinoma. | ESMO Gastrointest Oncol | 2026 | https://conductscience.org/library/papers/41994022 | PubMed |
| 41628233 | Loss of IL1RA promotes prostate cancer growth and metastasis by activating Akt signaling pathway. | PLoS One | 2026 | https://conductscience.org/library/papers/41628233 | PubMed |
| 41551149 | Prokaryotic organelle mitochondria drive tumorigenesis: "the original sin". | Front Oncol | 2025 | https://conductscience.org/library/papers/41551149 | PubMed |
| 39244734 | FHL2 expression by cancer-associated fibroblasts promotes metastasis and angiogenesis in lung adenocarcinoma. | Int J Cancer | 2025 | https://conductscience.org/library/papers/39244734 | PubMed |
| 38443748 | IL-33 aggravates extranodal NK/T cell lymphoma aggressiveness and angiogenesis by activating the Wnt/β-catenin signaling pathway. | Mol Cell Biochem | 2025 | https://conductscience.org/library/papers/38443748 | PubMed |
| 38125471 | Pyroptosis-related gene signature: A predictor for overall survival, immunotherapy response, and chemosensitivity in patients with pancreatic adenocarcinoma. | Heliyon | 2023 | https://conductscience.org/library/papers/38125471 | PubMed |
| 37198330 | IL-1RA inhibits esophageal carcinogenesis and lymphangiogenesis via downregulating VEGF-C and MMP9. | Funct Integr Genomics | 2023 | https://conductscience.org/library/papers/37198330 | PubMed |
| 37008817 | Evaluation of serum interleukin-1 receptor antagonist levels in major depressive disorder: A case-control study. | Health Sci Rep | 2023 | https://conductscience.org/library/papers/37008817 | PubMed |
| 36817666 | Increased IL-1α expression is correlated with bladder cancer malignant progression. | Arch Med Sci | 2023 | https://conductscience.org/library/papers/36817666 | PubMed |
| 36766731 | Transcriptomic and Functional Evidence That miRNA193a-3p Inhibits Lymphatic Endothelial Cell (LEC) and LEC + MCF-7 Spheroid Growth Directly and by Altering MCF-7 Secretome. | Cells | 2023 | https://conductscience.org/library/papers/36766731 | PubMed |
| 36175715 | The past, present, and future of immunotherapy for bladder tumors. | Med Oncol | 2022 | https://conductscience.org/library/papers/36175715 | PubMed |
| 35158807 | The Good, the Bad, and the Ugly: Neutrophils, Angiogenesis, and Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35158807 | PubMed |
| 35110359 | Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer. | J Immunother Cancer | 2022 | https://conductscience.org/library/papers/35110359 | PubMed |
| 35068869 | Issues of origin, morphology and clinical significance of tumor microvessels in gastric cancer. | World J Gastroenterol | 2021 | https://conductscience.org/library/papers/35068869 | PubMed |
| 35048046 | IL-1/IL-1R Signaling in Head and Neck Cancer. | Front Oral Health | 2021 | https://conductscience.org/library/papers/35048046 | PubMed |
| 35005769 | IL-1β promotes hypoxic vascular endothelial cell proliferation through the miR-24-3p/NKAP/NF-κB axis. | Biosci Rep | 2022 | https://conductscience.org/library/papers/35005769 | PubMed |
| 34290732 | KRT18 Modulates Alternative Splicing of Genes Involved in Proliferation and Apoptosis Processes in Both Gastric Cancer Cells and Clinical Samples. | Front Genet | 2021 | https://conductscience.org/library/papers/34290732 | PubMed |
| 34055022 | Effects of Berberine on Circular RNA Expression Profiles in Human Gastric Cancer Cells. | Evid Based Complement Alternat Med | 2021 | https://conductscience.org/library/papers/34055022 | PubMed |
| 33761051 | Treatment Strategies of Gastric Cancer-Molecular Targets for Anti-angiogenic Therapy: a State-of-the-art Review. | J Gastrointest Cancer | 2021 | https://conductscience.org/library/papers/33761051 | PubMed |
| 32408627 | Evidence for Cytoprotective Effect of Carbon Monoxide Donor in the Development of Acute Esophagitis Leading to Acute Esophageal Epithelium Lesions. | Cells | 2020 | https://conductscience.org/library/papers/32408627 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD44 | 960 | PubTator's text mining | https://conductscience.org/library/genes/960 | NCBI Gene |
| EGF | 1950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
| GAPDH | 2597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
| IL1A | 3552 | PubTator's text mining | https://conductscience.org/library/genes/3552 | NCBI Gene |
| IL1B | 3553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| IL1R1 | 3554 | PubTator's text mining | https://conductscience.org/library/genes/3554 | NCBI Gene |
| IL1RN | 3557 | PubTator's text mining | https://conductscience.org/library/genes/3557 | NCBI Gene |
| MET | 4233 | PubTator's text mining | https://conductscience.org/library/genes/4233 | NCBI Gene |
| PECAM1 | 5175 | PubTator's text mining | https://conductscience.org/library/genes/5175 | NCBI Gene |
| POTEF | 728378 | PubTator's text mining | https://conductscience.org/library/genes/728378 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29344744
GET https://conductscience.org/api/papers/v1/29344744/references?page=2